Results 71 to 80 of about 451,760 (295)

Eczema‐Like Amelanotic Melanoma: A Diagnostic Challenge

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Amelanotic melanoma (AM) is a rare and aggressive variant of cutaneous melanoma characterised by the absence of pigmentation, often leading to delayed diagnosis due to its ability to mimic benign inflammatory or neoplastic conditions. We report the case of a 68‐year‐old woman presenting with a slowly enlarging, erythematous, mildly scaling ...
Agata Janowska   +8 more
wiley   +1 more source

Breast Cancer Mimic: Cutaneous B-Cell Lymphoma Presenting as an Isolated Breast Mass

open access: yesCase Reports in Oncology, 2014
Background: Primary cutaneous B-cell lymphoma typically localizes to the skin, and dissemination to internal organs is rare. Lymphomatous involvement of the breasts is also rare.
Margaret Taghavi   +3 more
doaj   +1 more source

Not Just Mycosis Fungoides: A Case Series of Concurrent Fungal Infections in Patients With Cutaneous T‐Cell Lymphoma

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Mycosis fungoides is a misnomer that means ‘mushroom‐like fungal disease’, but it is, in fact, the most common form of cutaneous T‐cell lymphoma. The diagnosis of mycosis fungoides is often delayed due to non‐specific symptoms and cutaneous signs that mimic other common benign inflammatory dermatoses.
Ji Fung Yong   +5 more
wiley   +1 more source

Update on primary cutaneous T-cell lymphomas rare subtypes

open access: yesDermatology Reports
Rare subtypes of cutaneous T-cell lymphomas (CTCL) include four entities, primary cutaneous γδ T-cell lymphoma, primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma, and primary cutaneous CD4+ small/medium T-cell ...
Silvia Alberti-Violetti, Emilio Berti
doaj   +1 more source

Primary cutaneous anaplastic large cell lymphoma initially clinically considered to be pyoderma gangrenosum

open access: yesMedicine Science, 2017
Primary CD30+ anaplastic large cell lymphoma, which is generally seen in adults, is the second most common cutaneous T-cell lymphoma after mycosis fungoides. The lesions are characterized by red-brown plaque or nodules often with ulceration.
Serpil Sener   +2 more
doaj   +1 more source

Joint British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas

open access: yes, 2003
These guidelines for the management of cutaneous T-cell lymphoma have been prepared for dermatologists on behalf of the British Association of Dermatologists and the U.K. Cutaneous Lymphoma Group.
Marsden, J R   +3 more
core   +1 more source

Subcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives To summarise the demographic, clinical, histopathological, management and disease course of SPD.
Mason H. Crossman   +5 more
wiley   +1 more source

Cutaneous lymphomas, especially cutaneous T cell lymphoma.

open access: yesJournal of the Japan Society of the Reticuloendothelial System, 1994
Cutaneous Lymphomas, especially cutaneous T cell lymphoma (CTCL), which is a new disease entity of mycosis fungoides, Sezary syndrome and related disorders, were reviewed on the data of cutaneous lymphoma study group in Japan and our department.CTCL is one of the helper/inducer T cell malignancies. It is generally confined to the skin for a long period
Hiroshi Nakajima   +2 more
openaire   +3 more sources

Mycosis Fungoides: Tumour d′emblee

open access: yesIndian Dermatology Online Journal, 2012
Mycosis Fungoides is a Cutaneous T-cell lymphoma characterized by infiltration of skin with patches, plaques, and nodules composed of T-lymphocytes.
Rita Vora   +3 more
doaj   +1 more source

Clinical efficacy of zanolimumab (HuMax-CD4): Two phase 2 studies in refractory cutaneous T-cell lymphoma

open access: yes, 2007
The efficacy and safety of zanolimumab in patients with refractory cutaneous Tcell lymphoma (CTCL) have been assessed in two phase 2, multicenter, prospective, open-label, uncontrolled clinical studies.
Iversen, Lars   +33 more
core   +1 more source

Home - About - Disclaimer - Privacy